Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer's models
Mychael V Lourenco, Rudimar L Frozza, Guilherme B de Freitas, Hong Zhang, Grasielle C Kincheski, Felipe C Ribeiro, Rafaella A Gonçalves, Julia R Clarke, Danielle Beckman, Agnieszka Staniszewski, Hanna Berman, Lorena A Guerra, Letícia Forny-Germano, Shelby Meier, Donna M Wilcock, Jorge M de Souza, Soniza Alves-Leon, Vania F Prado, Marco A M Prado, Jose F Abisambra, Fernanda Tovar-Moll, Paulo Mattos, Ottavio Arancio, Sergio T Ferreira, Fernanda G De Felice, Mychael V Lourenco, Rudimar L Frozza, Guilherme B de Freitas, Hong Zhang, Grasielle C Kincheski, Felipe C Ribeiro, Rafaella A Gonçalves, Julia R Clarke, Danielle Beckman, Agnieszka Staniszewski, Hanna Berman, Lorena A Guerra, Letícia Forny-Germano, Shelby Meier, Donna M Wilcock, Jorge M de Souza, Soniza Alves-Leon, Vania F Prado, Marco A M Prado, Jose F Abisambra, Fernanda Tovar-Moll, Paulo Mattos, Ottavio Arancio, Sergio T Ferreira, Fernanda G De Felice
Abstract
Defective brain hormonal signaling has been associated with Alzheimer's disease (AD), a disorder characterized by synapse and memory failure. Irisin is an exercise-induced myokine released on cleavage of the membrane-bound precursor protein fibronectin type III domain-containing protein 5 (FNDC5), also expressed in the hippocampus. Here we show that FNDC5/irisin levels are reduced in AD hippocampi and cerebrospinal fluid, and in experimental AD models. Knockdown of brain FNDC5/irisin impairs long-term potentiation and novel object recognition memory in mice. Conversely, boosting brain levels of FNDC5/irisin rescues synaptic plasticity and memory in AD mouse models. Peripheral overexpression of FNDC5/irisin rescues memory impairment, whereas blockade of either peripheral or brain FNDC5/irisin attenuates the neuroprotective actions of physical exercise on synaptic plasticity and memory in AD mice. By showing that FNDC5/irisin is an important mediator of the beneficial effects of exercise in AD models, our findings place FNDC5/irisin as a novel agent capable of opposing synapse failure and memory impairment in AD.
Figures
![Extended Data Figure 1.. Validation of anti-FNDC5…](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6327967/bin/nihms-1511423-f0007.jpg)
![Extended Data Figure 2.. CSF and plasma…](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6327967/bin/nihms-1511423-f0008.jpg)
Extended Data Figure 3.. AβOs reduce FNDC5/irisin…
Extended Data Figure 3.. AβOs reduce FNDC5/irisin levels in hippocampal neurons.
(a-c) Primary cultured hippocampal…
Extended Data Figure 4.. AβOs reduce hippocampal…
Extended Data Figure 4.. AβOs reduce hippocampal FNDC5, PGC-1α and PPARγ expression.
(a) Hippocampal, cortical…
Extended Data Figure 5.. Lentiviral vectors expressing…
Extended Data Figure 5.. Lentiviral vectors expressing shFNDC5 did not cause motor impairment or affect…
Extended Data Figure 6.. Intrahippocampal administration of…
Extended Data Figure 6.. Intrahippocampal administration of recombinant irisin prevents AβO-induced memory impairment.
(a,b) Male…
Extended Data Figure 7.. Validation of PCR…
Extended Data Figure 7.. Validation of PCR array results by qPCR.
(a-f) AdFNDC5 expression of…
Extended Data Figure 8.. FNDC5/irisin rescues defective…
Extended Data Figure 8.. FNDC5/irisin rescues defective synaptic plasticity and memory in APP/PS1 M146L mice.
Extended Data Figure 9.. Irisin counteracts AD-linked…
Extended Data Figure 9.. Irisin counteracts AD-linked activation of cellular stress response and dendritic spine…
Extended Data Figure 10.. Exercise blocks AβO-induced…
Extended Data Figure 10.. Exercise blocks AβO-induced memory impairment in mice.
Effect of exercise (swimming;…
Figure 1.. CNS FNDC5/irisin is reduced in…
Figure 1.. CNS FNDC5/irisin is reduced in AD.
(a) Schematic representation of FNDC5 containing irisin,…
Figure 2.. Brain FNDC5/irisin is reduced in…
Figure 2.. Brain FNDC5/irisin is reduced in AD models.
Figure 3.. Downregulation of brain FNDC5/irisin impairs…
Figure 3.. Downregulation of brain FNDC5/irisin impairs synaptic plasticity and object recognition memory in mice.
Figure 4.. Brain FNDC5/irisin rescues defective synaptic…
Figure 4.. Brain FNDC5/irisin rescues defective synaptic plasticity and memory in AD mice.
(a,b) LTP…
Figure 5.. Irisin triggers brain cAMP/PKA/CREB signaling…
Figure 5.. Irisin triggers brain cAMP/PKA/CREB signaling pathways.
(a-d) Summary quantification of the effect of…
Figure 6.. FNDC5/irisin mediates the beneficial effects…
Figure 6.. FNDC5/irisin mediates the beneficial effects of exercise on synaptic plasticity and memory.
(a-b)…
- An exercise-induced messenger boosts memory in Alzheimer's disease.Chen X, Gan L. Chen X, et al. Nat Med. 2019 Jan;25(1):20-21. doi: 10.1038/s41591-018-0311-4. Nat Med. 2019. PMID: 30617321 No abstract available.
- Protective actions of exercise-related FNDC5/Irisin in memory and Alzheimer's disease.de Freitas GB, Lourenco MV, De Felice FG. de Freitas GB, et al. J Neurochem. 2020 Dec;155(6):602-611. doi: 10.1111/jnc.15039. Epub 2020 Jun 2. J Neurochem. 2020. PMID: 32396989 Review.
- Moderate treadmill exercise ameliorates amyloid-β-induced learning and memory impairment, possibly via increasing AMPK activity and up-regulation of the PGC-1α/FNDC5/BDNF pathway.Azimi M, Gharakhanlou R, Naghdi N, Khodadadi D, Heysieattalab S. Azimi M, et al. Peptides. 2018 Apr;102:78-88. doi: 10.1016/j.peptides.2017.12.027. Epub 2018 Jan 5. Peptides. 2018. PMID: 29309801
- Brain FNDC5/Irisin Expression in Patients and Mouse Models of Major Depression.Lima-Filho R, Fortuna JS, Cozachenco D, Isaac AR, Lyra E Silva N, Saldanha A, Santos LE, Ferreira ST, Lourenco MV, De Felice FG. Lima-Filho R, et al. eNeuro. 2023 Feb 13;10(2):ENEURO.0256-22.2023. doi: 10.1523/ENEURO.0256-22.2023. Print 2023 Feb. eNeuro. 2023. PMID: 36697257 Free PMC article.
- Time-Dependent Changes in Increased Levels of Plasma Irisin and Muscle PGC-1α and FNDC5 after Exercise in Mice.Pang M, Yang J, Rao J, Wang H, Zhang J, Wang S, Chen X, Dong X. Pang M, et al. Tohoku J Exp Med. 2018 Feb;244(2):93-103. doi: 10.1620/tjem.244.93. Tohoku J Exp Med. 2018. PMID: 29415899
- The novel exercise-induced hormone irisin protects against neuronal injury via activation of the Akt and ERK1/2 signaling pathways and contributes to the neuroprotection of physical exercise in cerebral ischemia.Li DJ, Li YH, Yuan HB, Qu LF, Wang P. Li DJ, et al. Metabolism. 2017 Mar;68:31-42. doi: 10.1016/j.metabol.2016.12.003. Epub 2016 Dec 11. Metabolism. 2017. PMID: 28183451
- Brain Vascular Health in ALS Is Mediated through Motor Cortex Microvascular Integrity.Schreiber S, Bernal J, Arndt P, Schreiber F, Müller P, Morton L, Braun-Dullaeus RC, Valdés-Hernández MDC, Duarte R, Wardlaw JM, Meuth SG, Mietzner G, Vielhaber S, Dunay IR, Dityatev A, Jandke S, Mattern H. Schreiber S, et al. Cells. 2023 Mar 21;12(6):957. doi: 10.3390/cells12060957. Cells. 2023. PMID: 36980297 Free PMC article. Review.
- Recombinant Irisin Protects Against Alveolar Bone Destruction During Orthodontic Tooth Movement.Wu S, Wang J, Liu L, Pang Y, Li Z, Mu H. Wu S, et al. Inflammation. 2023 Mar 15. doi: 10.1007/s10753-023-01797-3. Online ahead of print. Inflammation. 2023. PMID: 36918436
- The Impact of the Six Pillars of Lifestyle Medicine on Brain Health.Jaqua E, Biddy E, Moore C, Browne G. Jaqua E, et al. Cureus. 2023 Feb 3;15(2):e34605. doi: 10.7759/cureus.34605. eCollection 2023 Feb. Cureus. 2023. PMID: 36883088 Free PMC article. Review.
- Recent advances on the molecular mechanisms of exercise-induced improvements of cognitive dysfunction.Lu Y, Bu FQ, Wang F, Liu L, Zhang S, Wang G, Hu XY. Lu Y, et al. Transl Neurodegener. 2023 Feb 27;12(1):9. doi: 10.1186/s40035-023-00341-5. Transl Neurodegener. 2023. PMID: 36850004 Free PMC article. Review.
- Irisin: An anti-inflammatory exerkine in aging and redox-mediated comorbidities.Trettel CDS, Pelozin BRA, Barros MP, Bachi ALL, Braga PGS, Momesso CM, Furtado GE, Valente PA, Oliveira EM, Hogervorst E, Fernandes T. Trettel CDS, et al. Front Endocrinol (Lausanne). 2023 Feb 10;14:1106529. doi: 10.3389/fendo.2023.1106529. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36843614 Free PMC article. Review.
-
- Prince M, et al. The global prevalence of dementia: a systematic review and meta-analysis. Alzheimer’s & Dementia 9, 63–75 e62 (2013). - PubMed
-
- Fernandez AM & Torres-Alemán I The many faces of insulin-like peptide signalling in the brain. Nature Reviews Neuroscience 13, 225–239 (2012). - PubMed
-
- Biessels GJ & Reagan LP Hippocampal insulin resistance and cognitive dysfunction. Nature Reviews Neuroscience 16, 660–671 (2015). - PubMed
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- Adolescent
- Adult
- Aged
- Alzheimer Disease / cerebrospinal fluid
- Alzheimer Disease / genetics
- Alzheimer Disease / metabolism*
- Alzheimer Disease / physiopathology*
- Animals
- Brain / metabolism
- Brain / pathology
- Disease Models, Animal
- Down-Regulation
- Female
- Fibronectins / cerebrospinal fluid
- Fibronectins / genetics
- Fibronectins / metabolism*
- Humans
- Long-Term Potentiation
- Male
- Memory Disorders / complications*
- Memory Disorders / physiopathology*
- Mice, Inbred C57BL
- Middle Aged
- Neuronal Plasticity*
- Neuroprotective Agents / pharmacology
- Neuroprotective Agents / therapeutic use
- Physical Conditioning, Animal*
- RNA, Messenger / genetics
- RNA, Messenger / metabolism
- Recombinant Proteins / pharmacology
- Recombinant Proteins / therapeutic use
- Signal Transduction
- FNDC5 protein, human
- FNDC5 protein, mouse
- Fibronectins
- Neuroprotective Agents
- RNA, Messenger
- Recombinant Proteins
- Full Text Sources
- Other Literature Sources
- Medical
- Molecular Biology Databases
NCBI Literature Resources
The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.
National Library of Medicine
8600 Rockville Pike
Bethesda, MD 20894
![Extended Data Figure 3.. AβOs reduce FNDC5/irisin…](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6327967/bin/nihms-1511423-f0009.jpg)
Extended Data Figure 4.. AβOs reduce hippocampal…
Extended Data Figure 4.. AβOs reduce hippocampal FNDC5, PGC-1α and PPARγ expression.
(a) Hippocampal, cortical…
Extended Data Figure 5.. Lentiviral vectors expressing…
Extended Data Figure 5.. Lentiviral vectors expressing shFNDC5 did not cause motor impairment or affect…
Extended Data Figure 6.. Intrahippocampal administration of…
Extended Data Figure 6.. Intrahippocampal administration of recombinant irisin prevents AβO-induced memory impairment.
(a,b) Male…
Extended Data Figure 7.. Validation of PCR…
Extended Data Figure 7.. Validation of PCR array results by qPCR.
(a-f) AdFNDC5 expression of…
Extended Data Figure 8.. FNDC5/irisin rescues defective…
Extended Data Figure 8.. FNDC5/irisin rescues defective synaptic plasticity and memory in APP/PS1 M146L mice.
Extended Data Figure 9.. Irisin counteracts AD-linked…
Extended Data Figure 9.. Irisin counteracts AD-linked activation of cellular stress response and dendritic spine…
Extended Data Figure 10.. Exercise blocks AβO-induced…
Extended Data Figure 10.. Exercise blocks AβO-induced memory impairment in mice.
Effect of exercise (swimming;…
Figure 1.. CNS FNDC5/irisin is reduced in…
Figure 1.. CNS FNDC5/irisin is reduced in AD.
(a) Schematic representation of FNDC5 containing irisin,…
Figure 2.. Brain FNDC5/irisin is reduced in…
Figure 2.. Brain FNDC5/irisin is reduced in AD models.
Figure 3.. Downregulation of brain FNDC5/irisin impairs…
Figure 3.. Downregulation of brain FNDC5/irisin impairs synaptic plasticity and object recognition memory in mice.
Figure 4.. Brain FNDC5/irisin rescues defective synaptic…
Figure 4.. Brain FNDC5/irisin rescues defective synaptic plasticity and memory in AD mice.
(a,b) LTP…
Figure 5.. Irisin triggers brain cAMP/PKA/CREB signaling…
Figure 5.. Irisin triggers brain cAMP/PKA/CREB signaling pathways.
(a-d) Summary quantification of the effect of…
Figure 6.. FNDC5/irisin mediates the beneficial effects…
Figure 6.. FNDC5/irisin mediates the beneficial effects of exercise on synaptic plasticity and memory.
(a-b)…
- An exercise-induced messenger boosts memory in Alzheimer's disease.Chen X, Gan L. Chen X, et al. Nat Med. 2019 Jan;25(1):20-21. doi: 10.1038/s41591-018-0311-4. Nat Med. 2019. PMID: 30617321 No abstract available.
- Protective actions of exercise-related FNDC5/Irisin in memory and Alzheimer's disease.de Freitas GB, Lourenco MV, De Felice FG. de Freitas GB, et al. J Neurochem. 2020 Dec;155(6):602-611. doi: 10.1111/jnc.15039. Epub 2020 Jun 2. J Neurochem. 2020. PMID: 32396989 Review.
- Moderate treadmill exercise ameliorates amyloid-β-induced learning and memory impairment, possibly via increasing AMPK activity and up-regulation of the PGC-1α/FNDC5/BDNF pathway.Azimi M, Gharakhanlou R, Naghdi N, Khodadadi D, Heysieattalab S. Azimi M, et al. Peptides. 2018 Apr;102:78-88. doi: 10.1016/j.peptides.2017.12.027. Epub 2018 Jan 5. Peptides. 2018. PMID: 29309801
- Brain FNDC5/Irisin Expression in Patients and Mouse Models of Major Depression.Lima-Filho R, Fortuna JS, Cozachenco D, Isaac AR, Lyra E Silva N, Saldanha A, Santos LE, Ferreira ST, Lourenco MV, De Felice FG. Lima-Filho R, et al. eNeuro. 2023 Feb 13;10(2):ENEURO.0256-22.2023. doi: 10.1523/ENEURO.0256-22.2023. Print 2023 Feb. eNeuro. 2023. PMID: 36697257 Free PMC article.
- Time-Dependent Changes in Increased Levels of Plasma Irisin and Muscle PGC-1α and FNDC5 after Exercise in Mice.Pang M, Yang J, Rao J, Wang H, Zhang J, Wang S, Chen X, Dong X. Pang M, et al. Tohoku J Exp Med. 2018 Feb;244(2):93-103. doi: 10.1620/tjem.244.93. Tohoku J Exp Med. 2018. PMID: 29415899
- The novel exercise-induced hormone irisin protects against neuronal injury via activation of the Akt and ERK1/2 signaling pathways and contributes to the neuroprotection of physical exercise in cerebral ischemia.Li DJ, Li YH, Yuan HB, Qu LF, Wang P. Li DJ, et al. Metabolism. 2017 Mar;68:31-42. doi: 10.1016/j.metabol.2016.12.003. Epub 2016 Dec 11. Metabolism. 2017. PMID: 28183451
- Brain Vascular Health in ALS Is Mediated through Motor Cortex Microvascular Integrity.Schreiber S, Bernal J, Arndt P, Schreiber F, Müller P, Morton L, Braun-Dullaeus RC, Valdés-Hernández MDC, Duarte R, Wardlaw JM, Meuth SG, Mietzner G, Vielhaber S, Dunay IR, Dityatev A, Jandke S, Mattern H. Schreiber S, et al. Cells. 2023 Mar 21;12(6):957. doi: 10.3390/cells12060957. Cells. 2023. PMID: 36980297 Free PMC article. Review.
- Recombinant Irisin Protects Against Alveolar Bone Destruction During Orthodontic Tooth Movement.Wu S, Wang J, Liu L, Pang Y, Li Z, Mu H. Wu S, et al. Inflammation. 2023 Mar 15. doi: 10.1007/s10753-023-01797-3. Online ahead of print. Inflammation. 2023. PMID: 36918436
- The Impact of the Six Pillars of Lifestyle Medicine on Brain Health.Jaqua E, Biddy E, Moore C, Browne G. Jaqua E, et al. Cureus. 2023 Feb 3;15(2):e34605. doi: 10.7759/cureus.34605. eCollection 2023 Feb. Cureus. 2023. PMID: 36883088 Free PMC article. Review.
- Recent advances on the molecular mechanisms of exercise-induced improvements of cognitive dysfunction.Lu Y, Bu FQ, Wang F, Liu L, Zhang S, Wang G, Hu XY. Lu Y, et al. Transl Neurodegener. 2023 Feb 27;12(1):9. doi: 10.1186/s40035-023-00341-5. Transl Neurodegener. 2023. PMID: 36850004 Free PMC article. Review.
- Irisin: An anti-inflammatory exerkine in aging and redox-mediated comorbidities.Trettel CDS, Pelozin BRA, Barros MP, Bachi ALL, Braga PGS, Momesso CM, Furtado GE, Valente PA, Oliveira EM, Hogervorst E, Fernandes T. Trettel CDS, et al. Front Endocrinol (Lausanne). 2023 Feb 10;14:1106529. doi: 10.3389/fendo.2023.1106529. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36843614 Free PMC article. Review.
-
- Prince M, et al. The global prevalence of dementia: a systematic review and meta-analysis. Alzheimer’s & Dementia 9, 63–75 e62 (2013). - PubMed
-
- Fernandez AM & Torres-Alemán I The many faces of insulin-like peptide signalling in the brain. Nature Reviews Neuroscience 13, 225–239 (2012). - PubMed
-
- Biessels GJ & Reagan LP Hippocampal insulin resistance and cognitive dysfunction. Nature Reviews Neuroscience 16, 660–671 (2015). - PubMed
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- Adolescent
- Adult
- Aged
- Alzheimer Disease / cerebrospinal fluid
- Alzheimer Disease / genetics
- Alzheimer Disease / metabolism*
- Alzheimer Disease / physiopathology*
- Animals
- Brain / metabolism
- Brain / pathology
- Disease Models, Animal
- Down-Regulation
- Female
- Fibronectins / cerebrospinal fluid
- Fibronectins / genetics
- Fibronectins / metabolism*
- Humans
- Long-Term Potentiation
- Male
- Memory Disorders / complications*
- Memory Disorders / physiopathology*
- Mice, Inbred C57BL
- Middle Aged
- Neuronal Plasticity*
- Neuroprotective Agents / pharmacology
- Neuroprotective Agents / therapeutic use
- Physical Conditioning, Animal*
- RNA, Messenger / genetics
- RNA, Messenger / metabolism
- Recombinant Proteins / pharmacology
- Recombinant Proteins / therapeutic use
- Signal Transduction
- FNDC5 protein, human
- FNDC5 protein, mouse
- Fibronectins
- Neuroprotective Agents
- RNA, Messenger
- Recombinant Proteins
- Full Text Sources
- Other Literature Sources
- Medical
- Molecular Biology Databases
NCBI Literature Resources
The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.
National Library of Medicine
8600 Rockville Pike
Bethesda, MD 20894
![Extended Data Figure 4.. AβOs reduce hippocampal…](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6327967/bin/nihms-1511423-f0010.jpg)
Extended Data Figure 5.. Lentiviral vectors expressing…
Extended Data Figure 5.. Lentiviral vectors expressing shFNDC5 did not cause motor impairment or affect…
Extended Data Figure 6.. Intrahippocampal administration of…
Extended Data Figure 6.. Intrahippocampal administration of recombinant irisin prevents AβO-induced memory impairment.
(a,b) Male…
Extended Data Figure 7.. Validation of PCR…
Extended Data Figure 7.. Validation of PCR array results by qPCR.
(a-f) AdFNDC5 expression of…
Extended Data Figure 8.. FNDC5/irisin rescues defective…
Extended Data Figure 8.. FNDC5/irisin rescues defective synaptic plasticity and memory in APP/PS1 M146L mice.
Extended Data Figure 9.. Irisin counteracts AD-linked…
Extended Data Figure 9.. Irisin counteracts AD-linked activation of cellular stress response and dendritic spine…
Extended Data Figure 10.. Exercise blocks AβO-induced…
Extended Data Figure 10.. Exercise blocks AβO-induced memory impairment in mice.
Effect of exercise (swimming;…
Figure 1.. CNS FNDC5/irisin is reduced in…
Figure 1.. CNS FNDC5/irisin is reduced in AD.
(a) Schematic representation of FNDC5 containing irisin,…
Figure 2.. Brain FNDC5/irisin is reduced in…
Figure 2.. Brain FNDC5/irisin is reduced in AD models.
Figure 3.. Downregulation of brain FNDC5/irisin impairs…
Figure 3.. Downregulation of brain FNDC5/irisin impairs synaptic plasticity and object recognition memory in mice.
Figure 4.. Brain FNDC5/irisin rescues defective synaptic…
Figure 4.. Brain FNDC5/irisin rescues defective synaptic plasticity and memory in AD mice.
(a,b) LTP…
Figure 5.. Irisin triggers brain cAMP/PKA/CREB signaling…
Figure 5.. Irisin triggers brain cAMP/PKA/CREB signaling pathways.
(a-d) Summary quantification of the effect of…
Figure 6.. FNDC5/irisin mediates the beneficial effects…
Figure 6.. FNDC5/irisin mediates the beneficial effects of exercise on synaptic plasticity and memory.
(a-b)…
- An exercise-induced messenger boosts memory in Alzheimer's disease.Chen X, Gan L. Chen X, et al. Nat Med. 2019 Jan;25(1):20-21. doi: 10.1038/s41591-018-0311-4. Nat Med. 2019. PMID: 30617321 No abstract available.
- Protective actions of exercise-related FNDC5/Irisin in memory and Alzheimer's disease.de Freitas GB, Lourenco MV, De Felice FG. de Freitas GB, et al. J Neurochem. 2020 Dec;155(6):602-611. doi: 10.1111/jnc.15039. Epub 2020 Jun 2. J Neurochem. 2020. PMID: 32396989 Review.
- Moderate treadmill exercise ameliorates amyloid-β-induced learning and memory impairment, possibly via increasing AMPK activity and up-regulation of the PGC-1α/FNDC5/BDNF pathway.Azimi M, Gharakhanlou R, Naghdi N, Khodadadi D, Heysieattalab S. Azimi M, et al. Peptides. 2018 Apr;102:78-88. doi: 10.1016/j.peptides.2017.12.027. Epub 2018 Jan 5. Peptides. 2018. PMID: 29309801
- Brain FNDC5/Irisin Expression in Patients and Mouse Models of Major Depression.Lima-Filho R, Fortuna JS, Cozachenco D, Isaac AR, Lyra E Silva N, Saldanha A, Santos LE, Ferreira ST, Lourenco MV, De Felice FG. Lima-Filho R, et al. eNeuro. 2023 Feb 13;10(2):ENEURO.0256-22.2023. doi: 10.1523/ENEURO.0256-22.2023. Print 2023 Feb. eNeuro. 2023. PMID: 36697257 Free PMC article.
- Time-Dependent Changes in Increased Levels of Plasma Irisin and Muscle PGC-1α and FNDC5 after Exercise in Mice.Pang M, Yang J, Rao J, Wang H, Zhang J, Wang S, Chen X, Dong X. Pang M, et al. Tohoku J Exp Med. 2018 Feb;244(2):93-103. doi: 10.1620/tjem.244.93. Tohoku J Exp Med. 2018. PMID: 29415899
- The novel exercise-induced hormone irisin protects against neuronal injury via activation of the Akt and ERK1/2 signaling pathways and contributes to the neuroprotection of physical exercise in cerebral ischemia.Li DJ, Li YH, Yuan HB, Qu LF, Wang P. Li DJ, et al. Metabolism. 2017 Mar;68:31-42. doi: 10.1016/j.metabol.2016.12.003. Epub 2016 Dec 11. Metabolism. 2017. PMID: 28183451
- Brain Vascular Health in ALS Is Mediated through Motor Cortex Microvascular Integrity.Schreiber S, Bernal J, Arndt P, Schreiber F, Müller P, Morton L, Braun-Dullaeus RC, Valdés-Hernández MDC, Duarte R, Wardlaw JM, Meuth SG, Mietzner G, Vielhaber S, Dunay IR, Dityatev A, Jandke S, Mattern H. Schreiber S, et al. Cells. 2023 Mar 21;12(6):957. doi: 10.3390/cells12060957. Cells. 2023. PMID: 36980297 Free PMC article. Review.
- Recombinant Irisin Protects Against Alveolar Bone Destruction During Orthodontic Tooth Movement.Wu S, Wang J, Liu L, Pang Y, Li Z, Mu H. Wu S, et al. Inflammation. 2023 Mar 15. doi: 10.1007/s10753-023-01797-3. Online ahead of print. Inflammation. 2023. PMID: 36918436
- The Impact of the Six Pillars of Lifestyle Medicine on Brain Health.Jaqua E, Biddy E, Moore C, Browne G. Jaqua E, et al. Cureus. 2023 Feb 3;15(2):e34605. doi: 10.7759/cureus.34605. eCollection 2023 Feb. Cureus. 2023. PMID: 36883088 Free PMC article. Review.
- Recent advances on the molecular mechanisms of exercise-induced improvements of cognitive dysfunction.Lu Y, Bu FQ, Wang F, Liu L, Zhang S, Wang G, Hu XY. Lu Y, et al. Transl Neurodegener. 2023 Feb 27;12(1):9. doi: 10.1186/s40035-023-00341-5. Transl Neurodegener. 2023. PMID: 36850004 Free PMC article. Review.
- Irisin: An anti-inflammatory exerkine in aging and redox-mediated comorbidities.Trettel CDS, Pelozin BRA, Barros MP, Bachi ALL, Braga PGS, Momesso CM, Furtado GE, Valente PA, Oliveira EM, Hogervorst E, Fernandes T. Trettel CDS, et al. Front Endocrinol (Lausanne). 2023 Feb 10;14:1106529. doi: 10.3389/fendo.2023.1106529. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36843614 Free PMC article. Review.
-
- Prince M, et al. The global prevalence of dementia: a systematic review and meta-analysis. Alzheimer’s & Dementia 9, 63–75 e62 (2013). - PubMed
-
- Fernandez AM & Torres-Alemán I The many faces of insulin-like peptide signalling in the brain. Nature Reviews Neuroscience 13, 225–239 (2012). - PubMed
-
- Biessels GJ & Reagan LP Hippocampal insulin resistance and cognitive dysfunction. Nature Reviews Neuroscience 16, 660–671 (2015). - PubMed
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- Adolescent
- Adult
- Aged
- Alzheimer Disease / cerebrospinal fluid
- Alzheimer Disease / genetics
- Alzheimer Disease / metabolism*
- Alzheimer Disease / physiopathology*
- Animals
- Brain / metabolism
- Brain / pathology
- Disease Models, Animal
- Down-Regulation
- Female
- Fibronectins / cerebrospinal fluid
- Fibronectins / genetics
- Fibronectins / metabolism*
- Humans
- Long-Term Potentiation
- Male
- Memory Disorders / complications*
- Memory Disorders / physiopathology*
- Mice, Inbred C57BL
- Middle Aged
- Neuronal Plasticity*
- Neuroprotective Agents / pharmacology
- Neuroprotective Agents / therapeutic use
- Physical Conditioning, Animal*
- RNA, Messenger / genetics
- RNA, Messenger / metabolism
- Recombinant Proteins / pharmacology
- Recombinant Proteins / therapeutic use
- Signal Transduction
- FNDC5 protein, human
- FNDC5 protein, mouse
- Fibronectins
- Neuroprotective Agents
- RNA, Messenger
- Recombinant Proteins
- Full Text Sources
- Other Literature Sources
- Medical
- Molecular Biology Databases
NCBI Literature Resources
The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.
National Library of Medicine
8600 Rockville Pike
Bethesda, MD 20894
![Extended Data Figure 5.. Lentiviral vectors expressing…](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6327967/bin/nihms-1511423-f0011.jpg)
![Extended Data Figure 6.. Intrahippocampal administration of…](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6327967/bin/nihms-1511423-f0012.jpg)
Extended Data Figure 7.. Validation of PCR…
Extended Data Figure 7.. Validation of PCR array results by qPCR.
(a-f) AdFNDC5 expression of…
Extended Data Figure 8.. FNDC5/irisin rescues defective…
Extended Data Figure 8.. FNDC5/irisin rescues defective synaptic plasticity and memory in APP/PS1 M146L mice.
Extended Data Figure 9.. Irisin counteracts AD-linked…
Extended Data Figure 9.. Irisin counteracts AD-linked activation of cellular stress response and dendritic spine…
Extended Data Figure 10.. Exercise blocks AβO-induced…
Extended Data Figure 10.. Exercise blocks AβO-induced memory impairment in mice.
Effect of exercise (swimming;…
Figure 1.. CNS FNDC5/irisin is reduced in…
Figure 1.. CNS FNDC5/irisin is reduced in AD.
(a) Schematic representation of FNDC5 containing irisin,…
Figure 2.. Brain FNDC5/irisin is reduced in…
Figure 2.. Brain FNDC5/irisin is reduced in AD models.
Figure 3.. Downregulation of brain FNDC5/irisin impairs…
Figure 3.. Downregulation of brain FNDC5/irisin impairs synaptic plasticity and object recognition memory in mice.
Figure 4.. Brain FNDC5/irisin rescues defective synaptic…
Figure 4.. Brain FNDC5/irisin rescues defective synaptic plasticity and memory in AD mice.
(a,b) LTP…
Figure 5.. Irisin triggers brain cAMP/PKA/CREB signaling…
Figure 5.. Irisin triggers brain cAMP/PKA/CREB signaling pathways.
(a-d) Summary quantification of the effect of…
Figure 6.. FNDC5/irisin mediates the beneficial effects…
Figure 6.. FNDC5/irisin mediates the beneficial effects of exercise on synaptic plasticity and memory.
(a-b)…
- An exercise-induced messenger boosts memory in Alzheimer's disease.Chen X, Gan L. Chen X, et al. Nat Med. 2019 Jan;25(1):20-21. doi: 10.1038/s41591-018-0311-4. Nat Med. 2019. PMID: 30617321 No abstract available.
- Protective actions of exercise-related FNDC5/Irisin in memory and Alzheimer's disease.de Freitas GB, Lourenco MV, De Felice FG. de Freitas GB, et al. J Neurochem. 2020 Dec;155(6):602-611. doi: 10.1111/jnc.15039. Epub 2020 Jun 2. J Neurochem. 2020. PMID: 32396989 Review.
- Moderate treadmill exercise ameliorates amyloid-β-induced learning and memory impairment, possibly via increasing AMPK activity and up-regulation of the PGC-1α/FNDC5/BDNF pathway.Azimi M, Gharakhanlou R, Naghdi N, Khodadadi D, Heysieattalab S. Azimi M, et al. Peptides. 2018 Apr;102:78-88. doi: 10.1016/j.peptides.2017.12.027. Epub 2018 Jan 5. Peptides. 2018. PMID: 29309801
- Brain FNDC5/Irisin Expression in Patients and Mouse Models of Major Depression.Lima-Filho R, Fortuna JS, Cozachenco D, Isaac AR, Lyra E Silva N, Saldanha A, Santos LE, Ferreira ST, Lourenco MV, De Felice FG. Lima-Filho R, et al. eNeuro. 2023 Feb 13;10(2):ENEURO.0256-22.2023. doi: 10.1523/ENEURO.0256-22.2023. Print 2023 Feb. eNeuro. 2023. PMID: 36697257 Free PMC article.
- Time-Dependent Changes in Increased Levels of Plasma Irisin and Muscle PGC-1α and FNDC5 after Exercise in Mice.Pang M, Yang J, Rao J, Wang H, Zhang J, Wang S, Chen X, Dong X. Pang M, et al. Tohoku J Exp Med. 2018 Feb;244(2):93-103. doi: 10.1620/tjem.244.93. Tohoku J Exp Med. 2018. PMID: 29415899
- The novel exercise-induced hormone irisin protects against neuronal injury via activation of the Akt and ERK1/2 signaling pathways and contributes to the neuroprotection of physical exercise in cerebral ischemia.Li DJ, Li YH, Yuan HB, Qu LF, Wang P. Li DJ, et al. Metabolism. 2017 Mar;68:31-42. doi: 10.1016/j.metabol.2016.12.003. Epub 2016 Dec 11. Metabolism. 2017. PMID: 28183451
- Brain Vascular Health in ALS Is Mediated through Motor Cortex Microvascular Integrity.Schreiber S, Bernal J, Arndt P, Schreiber F, Müller P, Morton L, Braun-Dullaeus RC, Valdés-Hernández MDC, Duarte R, Wardlaw JM, Meuth SG, Mietzner G, Vielhaber S, Dunay IR, Dityatev A, Jandke S, Mattern H. Schreiber S, et al. Cells. 2023 Mar 21;12(6):957. doi: 10.3390/cells12060957. Cells. 2023. PMID: 36980297 Free PMC article. Review.
- Recombinant Irisin Protects Against Alveolar Bone Destruction During Orthodontic Tooth Movement.Wu S, Wang J, Liu L, Pang Y, Li Z, Mu H. Wu S, et al. Inflammation. 2023 Mar 15. doi: 10.1007/s10753-023-01797-3. Online ahead of print. Inflammation. 2023. PMID: 36918436
- The Impact of the Six Pillars of Lifestyle Medicine on Brain Health.Jaqua E, Biddy E, Moore C, Browne G. Jaqua E, et al. Cureus. 2023 Feb 3;15(2):e34605. doi: 10.7759/cureus.34605. eCollection 2023 Feb. Cureus. 2023. PMID: 36883088 Free PMC article. Review.
- Recent advances on the molecular mechanisms of exercise-induced improvements of cognitive dysfunction.Lu Y, Bu FQ, Wang F, Liu L, Zhang S, Wang G, Hu XY. Lu Y, et al. Transl Neurodegener. 2023 Feb 27;12(1):9. doi: 10.1186/s40035-023-00341-5. Transl Neurodegener. 2023. PMID: 36850004 Free PMC article. Review.
- Irisin: An anti-inflammatory exerkine in aging and redox-mediated comorbidities.Trettel CDS, Pelozin BRA, Barros MP, Bachi ALL, Braga PGS, Momesso CM, Furtado GE, Valente PA, Oliveira EM, Hogervorst E, Fernandes T. Trettel CDS, et al. Front Endocrinol (Lausanne). 2023 Feb 10;14:1106529. doi: 10.3389/fendo.2023.1106529. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36843614 Free PMC article. Review.
-
- Prince M, et al. The global prevalence of dementia: a systematic review and meta-analysis. Alzheimer’s & Dementia 9, 63–75 e62 (2013). - PubMed
-
- Fernandez AM & Torres-Alemán I The many faces of insulin-like peptide signalling in the brain. Nature Reviews Neuroscience 13, 225–239 (2012). - PubMed
-
- Biessels GJ & Reagan LP Hippocampal insulin resistance and cognitive dysfunction. Nature Reviews Neuroscience 16, 660–671 (2015). - PubMed
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- Adolescent
- Adult
- Aged
- Alzheimer Disease / cerebrospinal fluid
- Alzheimer Disease / genetics
- Alzheimer Disease / metabolism*
- Alzheimer Disease / physiopathology*
- Animals
- Brain / metabolism
- Brain / pathology
- Disease Models, Animal
- Down-Regulation
- Female
- Fibronectins / cerebrospinal fluid
- Fibronectins / genetics
- Fibronectins / metabolism*
- Humans
- Long-Term Potentiation
- Male
- Memory Disorders / complications*
- Memory Disorders / physiopathology*
- Mice, Inbred C57BL
- Middle Aged
- Neuronal Plasticity*
- Neuroprotective Agents / pharmacology
- Neuroprotective Agents / therapeutic use
- Physical Conditioning, Animal*
- RNA, Messenger / genetics
- RNA, Messenger / metabolism
- Recombinant Proteins / pharmacology
- Recombinant Proteins / therapeutic use
- Signal Transduction
- FNDC5 protein, human
- FNDC5 protein, mouse
- Fibronectins
- Neuroprotective Agents
- RNA, Messenger
- Recombinant Proteins
- Full Text Sources
- Other Literature Sources
- Medical
- Molecular Biology Databases
NCBI Literature Resources
The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.
National Library of Medicine
8600 Rockville Pike
Bethesda, MD 20894
![Extended Data Figure 7.. Validation of PCR…](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6327967/bin/nihms-1511423-f0013.jpg)
Extended Data Figure 8.. FNDC5/irisin rescues defective…
Extended Data Figure 8.. FNDC5/irisin rescues defective synaptic plasticity and memory in APP/PS1 M146L mice.
Extended Data Figure 9.. Irisin counteracts AD-linked…
Extended Data Figure 9.. Irisin counteracts AD-linked activation of cellular stress response and dendritic spine…
Extended Data Figure 10.. Exercise blocks AβO-induced…
Extended Data Figure 10.. Exercise blocks AβO-induced memory impairment in mice.
Effect of exercise (swimming;…
Figure 1.. CNS FNDC5/irisin is reduced in…
Figure 1.. CNS FNDC5/irisin is reduced in AD.
(a) Schematic representation of FNDC5 containing irisin,…
Figure 2.. Brain FNDC5/irisin is reduced in…
Figure 2.. Brain FNDC5/irisin is reduced in AD models.
Figure 3.. Downregulation of brain FNDC5/irisin impairs…
Figure 3.. Downregulation of brain FNDC5/irisin impairs synaptic plasticity and object recognition memory in mice.
Figure 4.. Brain FNDC5/irisin rescues defective synaptic…
Figure 4.. Brain FNDC5/irisin rescues defective synaptic plasticity and memory in AD mice.
(a,b) LTP…
Figure 5.. Irisin triggers brain cAMP/PKA/CREB signaling…
Figure 5.. Irisin triggers brain cAMP/PKA/CREB signaling pathways.
(a-d) Summary quantification of the effect of…
Figure 6.. FNDC5/irisin mediates the beneficial effects…
Figure 6.. FNDC5/irisin mediates the beneficial effects of exercise on synaptic plasticity and memory.
(a-b)…
- An exercise-induced messenger boosts memory in Alzheimer's disease.Chen X, Gan L. Chen X, et al. Nat Med. 2019 Jan;25(1):20-21. doi: 10.1038/s41591-018-0311-4. Nat Med. 2019. PMID: 30617321 No abstract available.
- Protective actions of exercise-related FNDC5/Irisin in memory and Alzheimer's disease.de Freitas GB, Lourenco MV, De Felice FG. de Freitas GB, et al. J Neurochem. 2020 Dec;155(6):602-611. doi: 10.1111/jnc.15039. Epub 2020 Jun 2. J Neurochem. 2020. PMID: 32396989 Review.
- Moderate treadmill exercise ameliorates amyloid-β-induced learning and memory impairment, possibly via increasing AMPK activity and up-regulation of the PGC-1α/FNDC5/BDNF pathway.Azimi M, Gharakhanlou R, Naghdi N, Khodadadi D, Heysieattalab S. Azimi M, et al. Peptides. 2018 Apr;102:78-88. doi: 10.1016/j.peptides.2017.12.027. Epub 2018 Jan 5. Peptides. 2018. PMID: 29309801
- Brain FNDC5/Irisin Expression in Patients and Mouse Models of Major Depression.Lima-Filho R, Fortuna JS, Cozachenco D, Isaac AR, Lyra E Silva N, Saldanha A, Santos LE, Ferreira ST, Lourenco MV, De Felice FG. Lima-Filho R, et al. eNeuro. 2023 Feb 13;10(2):ENEURO.0256-22.2023. doi: 10.1523/ENEURO.0256-22.2023. Print 2023 Feb. eNeuro. 2023. PMID: 36697257 Free PMC article.
- Time-Dependent Changes in Increased Levels of Plasma Irisin and Muscle PGC-1α and FNDC5 after Exercise in Mice.Pang M, Yang J, Rao J, Wang H, Zhang J, Wang S, Chen X, Dong X. Pang M, et al. Tohoku J Exp Med. 2018 Feb;244(2):93-103. doi: 10.1620/tjem.244.93. Tohoku J Exp Med. 2018. PMID: 29415899
- The novel exercise-induced hormone irisin protects against neuronal injury via activation of the Akt and ERK1/2 signaling pathways and contributes to the neuroprotection of physical exercise in cerebral ischemia.Li DJ, Li YH, Yuan HB, Qu LF, Wang P. Li DJ, et al. Metabolism. 2017 Mar;68:31-42. doi: 10.1016/j.metabol.2016.12.003. Epub 2016 Dec 11. Metabolism. 2017. PMID: 28183451
- Brain Vascular Health in ALS Is Mediated through Motor Cortex Microvascular Integrity.Schreiber S, Bernal J, Arndt P, Schreiber F, Müller P, Morton L, Braun-Dullaeus RC, Valdés-Hernández MDC, Duarte R, Wardlaw JM, Meuth SG, Mietzner G, Vielhaber S, Dunay IR, Dityatev A, Jandke S, Mattern H. Schreiber S, et al. Cells. 2023 Mar 21;12(6):957. doi: 10.3390/cells12060957. Cells. 2023. PMID: 36980297 Free PMC article. Review.
- Recombinant Irisin Protects Against Alveolar Bone Destruction During Orthodontic Tooth Movement.Wu S, Wang J, Liu L, Pang Y, Li Z, Mu H. Wu S, et al. Inflammation. 2023 Mar 15. doi: 10.1007/s10753-023-01797-3. Online ahead of print. Inflammation. 2023. PMID: 36918436
- The Impact of the Six Pillars of Lifestyle Medicine on Brain Health.Jaqua E, Biddy E, Moore C, Browne G. Jaqua E, et al. Cureus. 2023 Feb 3;15(2):e34605. doi: 10.7759/cureus.34605. eCollection 2023 Feb. Cureus. 2023. PMID: 36883088 Free PMC article. Review.
- Recent advances on the molecular mechanisms of exercise-induced improvements of cognitive dysfunction.Lu Y, Bu FQ, Wang F, Liu L, Zhang S, Wang G, Hu XY. Lu Y, et al. Transl Neurodegener. 2023 Feb 27;12(1):9. doi: 10.1186/s40035-023-00341-5. Transl Neurodegener. 2023. PMID: 36850004 Free PMC article. Review.
- Irisin: An anti-inflammatory exerkine in aging and redox-mediated comorbidities.Trettel CDS, Pelozin BRA, Barros MP, Bachi ALL, Braga PGS, Momesso CM, Furtado GE, Valente PA, Oliveira EM, Hogervorst E, Fernandes T. Trettel CDS, et al. Front Endocrinol (Lausanne). 2023 Feb 10;14:1106529. doi: 10.3389/fendo.2023.1106529. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36843614 Free PMC article. Review.
-
- Prince M, et al. The global prevalence of dementia: a systematic review and meta-analysis. Alzheimer’s & Dementia 9, 63–75 e62 (2013). - PubMed
-
- Fernandez AM & Torres-Alemán I The many faces of insulin-like peptide signalling in the brain. Nature Reviews Neuroscience 13, 225–239 (2012). - PubMed
-
- Biessels GJ & Reagan LP Hippocampal insulin resistance and cognitive dysfunction. Nature Reviews Neuroscience 16, 660–671 (2015). - PubMed
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- Adolescent
- Adult
- Aged
- Alzheimer Disease / cerebrospinal fluid
- Alzheimer Disease / genetics
- Alzheimer Disease / metabolism*
- Alzheimer Disease / physiopathology*
- Animals
- Brain / metabolism
- Brain / pathology
- Disease Models, Animal
- Down-Regulation
- Female
- Fibronectins / cerebrospinal fluid
- Fibronectins / genetics
- Fibronectins / metabolism*
- Humans
- Long-Term Potentiation
- Male
- Memory Disorders / complications*
- Memory Disorders / physiopathology*
- Mice, Inbred C57BL
- Middle Aged
- Neuronal Plasticity*
- Neuroprotective Agents / pharmacology
- Neuroprotective Agents / therapeutic use
- Physical Conditioning, Animal*
- RNA, Messenger / genetics
- RNA, Messenger / metabolism
- Recombinant Proteins / pharmacology
- Recombinant Proteins / therapeutic use
- Signal Transduction
- FNDC5 protein, human
- FNDC5 protein, mouse
- Fibronectins
- Neuroprotective Agents
- RNA, Messenger
- Recombinant Proteins
- Full Text Sources
- Other Literature Sources
- Medical
- Molecular Biology Databases
NCBI Literature Resources
The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.
National Library of Medicine
8600 Rockville Pike
Bethesda, MD 20894
![Extended Data Figure 8.. FNDC5/irisin rescues defective…](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6327967/bin/nihms-1511423-f0014.jpg)
Extended Data Figure 9.. Irisin counteracts AD-linked…
Extended Data Figure 9.. Irisin counteracts AD-linked activation of cellular stress response and dendritic spine…
Extended Data Figure 10.. Exercise blocks AβO-induced…
Extended Data Figure 10.. Exercise blocks AβO-induced memory impairment in mice.
Effect of exercise (swimming;…
Figure 1.. CNS FNDC5/irisin is reduced in…
Figure 1.. CNS FNDC5/irisin is reduced in AD.
(a) Schematic representation of FNDC5 containing irisin,…
Figure 2.. Brain FNDC5/irisin is reduced in…
Figure 2.. Brain FNDC5/irisin is reduced in AD models.
Figure 3.. Downregulation of brain FNDC5/irisin impairs…
Figure 3.. Downregulation of brain FNDC5/irisin impairs synaptic plasticity and object recognition memory in mice.
Figure 4.. Brain FNDC5/irisin rescues defective synaptic…
Figure 4.. Brain FNDC5/irisin rescues defective synaptic plasticity and memory in AD mice.
(a,b) LTP…
Figure 5.. Irisin triggers brain cAMP/PKA/CREB signaling…
Figure 5.. Irisin triggers brain cAMP/PKA/CREB signaling pathways.
(a-d) Summary quantification of the effect of…
Figure 6.. FNDC5/irisin mediates the beneficial effects…
Figure 6.. FNDC5/irisin mediates the beneficial effects of exercise on synaptic plasticity and memory.
(a-b)…
- An exercise-induced messenger boosts memory in Alzheimer's disease.Chen X, Gan L. Chen X, et al. Nat Med. 2019 Jan;25(1):20-21. doi: 10.1038/s41591-018-0311-4. Nat Med. 2019. PMID: 30617321 No abstract available.
- Protective actions of exercise-related FNDC5/Irisin in memory and Alzheimer's disease.de Freitas GB, Lourenco MV, De Felice FG. de Freitas GB, et al. J Neurochem. 2020 Dec;155(6):602-611. doi: 10.1111/jnc.15039. Epub 2020 Jun 2. J Neurochem. 2020. PMID: 32396989 Review.
- Moderate treadmill exercise ameliorates amyloid-β-induced learning and memory impairment, possibly via increasing AMPK activity and up-regulation of the PGC-1α/FNDC5/BDNF pathway.Azimi M, Gharakhanlou R, Naghdi N, Khodadadi D, Heysieattalab S. Azimi M, et al. Peptides. 2018 Apr;102:78-88. doi: 10.1016/j.peptides.2017.12.027. Epub 2018 Jan 5. Peptides. 2018. PMID: 29309801
- Brain FNDC5/Irisin Expression in Patients and Mouse Models of Major Depression.Lima-Filho R, Fortuna JS, Cozachenco D, Isaac AR, Lyra E Silva N, Saldanha A, Santos LE, Ferreira ST, Lourenco MV, De Felice FG. Lima-Filho R, et al. eNeuro. 2023 Feb 13;10(2):ENEURO.0256-22.2023. doi: 10.1523/ENEURO.0256-22.2023. Print 2023 Feb. eNeuro. 2023. PMID: 36697257 Free PMC article.
- Time-Dependent Changes in Increased Levels of Plasma Irisin and Muscle PGC-1α and FNDC5 after Exercise in Mice.Pang M, Yang J, Rao J, Wang H, Zhang J, Wang S, Chen X, Dong X. Pang M, et al. Tohoku J Exp Med. 2018 Feb;244(2):93-103. doi: 10.1620/tjem.244.93. Tohoku J Exp Med. 2018. PMID: 29415899
- The novel exercise-induced hormone irisin protects against neuronal injury via activation of the Akt and ERK1/2 signaling pathways and contributes to the neuroprotection of physical exercise in cerebral ischemia.Li DJ, Li YH, Yuan HB, Qu LF, Wang P. Li DJ, et al. Metabolism. 2017 Mar;68:31-42. doi: 10.1016/j.metabol.2016.12.003. Epub 2016 Dec 11. Metabolism. 2017. PMID: 28183451
- Brain Vascular Health in ALS Is Mediated through Motor Cortex Microvascular Integrity.Schreiber S, Bernal J, Arndt P, Schreiber F, Müller P, Morton L, Braun-Dullaeus RC, Valdés-Hernández MDC, Duarte R, Wardlaw JM, Meuth SG, Mietzner G, Vielhaber S, Dunay IR, Dityatev A, Jandke S, Mattern H. Schreiber S, et al. Cells. 2023 Mar 21;12(6):957. doi: 10.3390/cells12060957. Cells. 2023. PMID: 36980297 Free PMC article. Review.
- Recombinant Irisin Protects Against Alveolar Bone Destruction During Orthodontic Tooth Movement.Wu S, Wang J, Liu L, Pang Y, Li Z, Mu H. Wu S, et al. Inflammation. 2023 Mar 15. doi: 10.1007/s10753-023-01797-3. Online ahead of print. Inflammation. 2023. PMID: 36918436
- The Impact of the Six Pillars of Lifestyle Medicine on Brain Health.Jaqua E, Biddy E, Moore C, Browne G. Jaqua E, et al. Cureus. 2023 Feb 3;15(2):e34605. doi: 10.7759/cureus.34605. eCollection 2023 Feb. Cureus. 2023. PMID: 36883088 Free PMC article. Review.
- Recent advances on the molecular mechanisms of exercise-induced improvements of cognitive dysfunction.Lu Y, Bu FQ, Wang F, Liu L, Zhang S, Wang G, Hu XY. Lu Y, et al. Transl Neurodegener. 2023 Feb 27;12(1):9. doi: 10.1186/s40035-023-00341-5. Transl Neurodegener. 2023. PMID: 36850004 Free PMC article. Review.
- Irisin: An anti-inflammatory exerkine in aging and redox-mediated comorbidities.Trettel CDS, Pelozin BRA, Barros MP, Bachi ALL, Braga PGS, Momesso CM, Furtado GE, Valente PA, Oliveira EM, Hogervorst E, Fernandes T. Trettel CDS, et al. Front Endocrinol (Lausanne). 2023 Feb 10;14:1106529. doi: 10.3389/fendo.2023.1106529. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36843614 Free PMC article. Review.
-
- Prince M, et al. The global prevalence of dementia: a systematic review and meta-analysis. Alzheimer’s & Dementia 9, 63–75 e62 (2013). - PubMed
-
- Fernandez AM & Torres-Alemán I The many faces of insulin-like peptide signalling in the brain. Nature Reviews Neuroscience 13, 225–239 (2012). - PubMed
-
- Biessels GJ & Reagan LP Hippocampal insulin resistance and cognitive dysfunction. Nature Reviews Neuroscience 16, 660–671 (2015). - PubMed
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- Adolescent
- Adult
- Aged
- Alzheimer Disease / cerebrospinal fluid
- Alzheimer Disease / genetics
- Alzheimer Disease / metabolism*
- Alzheimer Disease / physiopathology*
- Animals
- Brain / metabolism
- Brain / pathology
- Disease Models, Animal
- Down-Regulation
- Female
- Fibronectins / cerebrospinal fluid
- Fibronectins / genetics
- Fibronectins / metabolism*
- Humans
- Long-Term Potentiation
- Male
- Memory Disorders / complications*
- Memory Disorders / physiopathology*
- Mice, Inbred C57BL
- Middle Aged
- Neuronal Plasticity*
- Neuroprotective Agents / pharmacology
- Neuroprotective Agents / therapeutic use
- Physical Conditioning, Animal*
- RNA, Messenger / genetics
- RNA, Messenger / metabolism
- Recombinant Proteins / pharmacology
- Recombinant Proteins / therapeutic use
- Signal Transduction
- FNDC5 protein, human
- FNDC5 protein, mouse
- Fibronectins
- Neuroprotective Agents
- RNA, Messenger
- Recombinant Proteins
- Full Text Sources
- Other Literature Sources
- Medical
- Molecular Biology Databases
NCBI Literature Resources
The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.
National Library of Medicine
8600 Rockville Pike
Bethesda, MD 20894
![Extended Data Figure 9.. Irisin counteracts AD-linked…](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6327967/bin/nihms-1511423-f0015.jpg)
![Extended Data Figure 10.. Exercise blocks AβO-induced…](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6327967/bin/nihms-1511423-f0016.jpg)
Figure 1.. CNS FNDC5/irisin is reduced in…
Figure 1.. CNS FNDC5/irisin is reduced in AD.
(a) Schematic representation of FNDC5 containing irisin,…
Figure 2.. Brain FNDC5/irisin is reduced in…
Figure 2.. Brain FNDC5/irisin is reduced in AD models.
Figure 3.. Downregulation of brain FNDC5/irisin impairs…
Figure 3.. Downregulation of brain FNDC5/irisin impairs synaptic plasticity and object recognition memory in mice.
Figure 4.. Brain FNDC5/irisin rescues defective synaptic…
Figure 4.. Brain FNDC5/irisin rescues defective synaptic plasticity and memory in AD mice.
(a,b) LTP…
Figure 5.. Irisin triggers brain cAMP/PKA/CREB signaling…
Figure 5.. Irisin triggers brain cAMP/PKA/CREB signaling pathways.
(a-d) Summary quantification of the effect of…
Figure 6.. FNDC5/irisin mediates the beneficial effects…
Figure 6.. FNDC5/irisin mediates the beneficial effects of exercise on synaptic plasticity and memory.
(a-b)…
- An exercise-induced messenger boosts memory in Alzheimer's disease.Chen X, Gan L. Chen X, et al. Nat Med. 2019 Jan;25(1):20-21. doi: 10.1038/s41591-018-0311-4. Nat Med. 2019. PMID: 30617321 No abstract available.
- Protective actions of exercise-related FNDC5/Irisin in memory and Alzheimer's disease.de Freitas GB, Lourenco MV, De Felice FG. de Freitas GB, et al. J Neurochem. 2020 Dec;155(6):602-611. doi: 10.1111/jnc.15039. Epub 2020 Jun 2. J Neurochem. 2020. PMID: 32396989 Review.
- Moderate treadmill exercise ameliorates amyloid-β-induced learning and memory impairment, possibly via increasing AMPK activity and up-regulation of the PGC-1α/FNDC5/BDNF pathway.Azimi M, Gharakhanlou R, Naghdi N, Khodadadi D, Heysieattalab S. Azimi M, et al. Peptides. 2018 Apr;102:78-88. doi: 10.1016/j.peptides.2017.12.027. Epub 2018 Jan 5. Peptides. 2018. PMID: 29309801
- Brain FNDC5/Irisin Expression in Patients and Mouse Models of Major Depression.Lima-Filho R, Fortuna JS, Cozachenco D, Isaac AR, Lyra E Silva N, Saldanha A, Santos LE, Ferreira ST, Lourenco MV, De Felice FG. Lima-Filho R, et al. eNeuro. 2023 Feb 13;10(2):ENEURO.0256-22.2023. doi: 10.1523/ENEURO.0256-22.2023. Print 2023 Feb. eNeuro. 2023. PMID: 36697257 Free PMC article.
- Time-Dependent Changes in Increased Levels of Plasma Irisin and Muscle PGC-1α and FNDC5 after Exercise in Mice.Pang M, Yang J, Rao J, Wang H, Zhang J, Wang S, Chen X, Dong X. Pang M, et al. Tohoku J Exp Med. 2018 Feb;244(2):93-103. doi: 10.1620/tjem.244.93. Tohoku J Exp Med. 2018. PMID: 29415899
- The novel exercise-induced hormone irisin protects against neuronal injury via activation of the Akt and ERK1/2 signaling pathways and contributes to the neuroprotection of physical exercise in cerebral ischemia.Li DJ, Li YH, Yuan HB, Qu LF, Wang P. Li DJ, et al. Metabolism. 2017 Mar;68:31-42. doi: 10.1016/j.metabol.2016.12.003. Epub 2016 Dec 11. Metabolism. 2017. PMID: 28183451
- Brain Vascular Health in ALS Is Mediated through Motor Cortex Microvascular Integrity.Schreiber S, Bernal J, Arndt P, Schreiber F, Müller P, Morton L, Braun-Dullaeus RC, Valdés-Hernández MDC, Duarte R, Wardlaw JM, Meuth SG, Mietzner G, Vielhaber S, Dunay IR, Dityatev A, Jandke S, Mattern H. Schreiber S, et al. Cells. 2023 Mar 21;12(6):957. doi: 10.3390/cells12060957. Cells. 2023. PMID: 36980297 Free PMC article. Review.
- Recombinant Irisin Protects Against Alveolar Bone Destruction During Orthodontic Tooth Movement.Wu S, Wang J, Liu L, Pang Y, Li Z, Mu H. Wu S, et al. Inflammation. 2023 Mar 15. doi: 10.1007/s10753-023-01797-3. Online ahead of print. Inflammation. 2023. PMID: 36918436
- The Impact of the Six Pillars of Lifestyle Medicine on Brain Health.Jaqua E, Biddy E, Moore C, Browne G. Jaqua E, et al. Cureus. 2023 Feb 3;15(2):e34605. doi: 10.7759/cureus.34605. eCollection 2023 Feb. Cureus. 2023. PMID: 36883088 Free PMC article. Review.
- Recent advances on the molecular mechanisms of exercise-induced improvements of cognitive dysfunction.Lu Y, Bu FQ, Wang F, Liu L, Zhang S, Wang G, Hu XY. Lu Y, et al. Transl Neurodegener. 2023 Feb 27;12(1):9. doi: 10.1186/s40035-023-00341-5. Transl Neurodegener. 2023. PMID: 36850004 Free PMC article. Review.
- Irisin: An anti-inflammatory exerkine in aging and redox-mediated comorbidities.Trettel CDS, Pelozin BRA, Barros MP, Bachi ALL, Braga PGS, Momesso CM, Furtado GE, Valente PA, Oliveira EM, Hogervorst E, Fernandes T. Trettel CDS, et al. Front Endocrinol (Lausanne). 2023 Feb 10;14:1106529. doi: 10.3389/fendo.2023.1106529. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36843614 Free PMC article. Review.
-
- Prince M, et al. The global prevalence of dementia: a systematic review and meta-analysis. Alzheimer’s & Dementia 9, 63–75 e62 (2013). - PubMed
-
- Fernandez AM & Torres-Alemán I The many faces of insulin-like peptide signalling in the brain. Nature Reviews Neuroscience 13, 225–239 (2012). - PubMed
-
- Biessels GJ & Reagan LP Hippocampal insulin resistance and cognitive dysfunction. Nature Reviews Neuroscience 16, 660–671 (2015). - PubMed
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- Adolescent
- Adult
- Aged
- Alzheimer Disease / cerebrospinal fluid
- Alzheimer Disease / genetics
- Alzheimer Disease / metabolism*
- Alzheimer Disease / physiopathology*
- Animals
- Brain / metabolism
- Brain / pathology
- Disease Models, Animal
- Down-Regulation
- Female
- Fibronectins / cerebrospinal fluid
- Fibronectins / genetics
- Fibronectins / metabolism*
- Humans
- Long-Term Potentiation
- Male
- Memory Disorders / complications*
- Memory Disorders / physiopathology*
- Mice, Inbred C57BL
- Middle Aged
- Neuronal Plasticity*
- Neuroprotective Agents / pharmacology
- Neuroprotective Agents / therapeutic use
- Physical Conditioning, Animal*
- RNA, Messenger / genetics
- RNA, Messenger / metabolism
- Recombinant Proteins / pharmacology
- Recombinant Proteins / therapeutic use
- Signal Transduction
- FNDC5 protein, human
- FNDC5 protein, mouse
- Fibronectins
- Neuroprotective Agents
- RNA, Messenger
- Recombinant Proteins
- Full Text Sources
- Other Literature Sources
- Medical
- Molecular Biology Databases
NCBI Literature Resources
The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.
National Library of Medicine
8600 Rockville Pike
Bethesda, MD 20894
![Figure 1.. CNS FNDC5/irisin is reduced in…](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6327967/bin/nihms-1511423-f0001.jpg)
![Figure 2.. Brain FNDC5/irisin is reduced in…](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6327967/bin/nihms-1511423-f0002.jpg)
![Figure 3.. Downregulation of brain FNDC5/irisin impairs…](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6327967/bin/nihms-1511423-f0003.jpg)
![Figure 4.. Brain FNDC5/irisin rescues defective synaptic…](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6327967/bin/nihms-1511423-f0004.jpg)
![Figure 5.. Irisin triggers brain cAMP/PKA/CREB signaling…](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6327967/bin/nihms-1511423-f0005.jpg)
Figure 6.. FNDC5/irisin mediates the beneficial effects…
Figure 6.. FNDC5/irisin mediates the beneficial effects of exercise on synaptic plasticity and memory.
(a-b)…
- An exercise-induced messenger boosts memory in Alzheimer's disease.Chen X, Gan L. Chen X, et al. Nat Med. 2019 Jan;25(1):20-21. doi: 10.1038/s41591-018-0311-4. Nat Med. 2019. PMID: 30617321 No abstract available.
- Protective actions of exercise-related FNDC5/Irisin in memory and Alzheimer's disease.de Freitas GB, Lourenco MV, De Felice FG. de Freitas GB, et al. J Neurochem. 2020 Dec;155(6):602-611. doi: 10.1111/jnc.15039. Epub 2020 Jun 2. J Neurochem. 2020. PMID: 32396989 Review.
- Moderate treadmill exercise ameliorates amyloid-β-induced learning and memory impairment, possibly via increasing AMPK activity and up-regulation of the PGC-1α/FNDC5/BDNF pathway.Azimi M, Gharakhanlou R, Naghdi N, Khodadadi D, Heysieattalab S. Azimi M, et al. Peptides. 2018 Apr;102:78-88. doi: 10.1016/j.peptides.2017.12.027. Epub 2018 Jan 5. Peptides. 2018. PMID: 29309801
- Brain FNDC5/Irisin Expression in Patients and Mouse Models of Major Depression.Lima-Filho R, Fortuna JS, Cozachenco D, Isaac AR, Lyra E Silva N, Saldanha A, Santos LE, Ferreira ST, Lourenco MV, De Felice FG. Lima-Filho R, et al. eNeuro. 2023 Feb 13;10(2):ENEURO.0256-22.2023. doi: 10.1523/ENEURO.0256-22.2023. Print 2023 Feb. eNeuro. 2023. PMID: 36697257 Free PMC article.
- Time-Dependent Changes in Increased Levels of Plasma Irisin and Muscle PGC-1α and FNDC5 after Exercise in Mice.Pang M, Yang J, Rao J, Wang H, Zhang J, Wang S, Chen X, Dong X. Pang M, et al. Tohoku J Exp Med. 2018 Feb;244(2):93-103. doi: 10.1620/tjem.244.93. Tohoku J Exp Med. 2018. PMID: 29415899
- The novel exercise-induced hormone irisin protects against neuronal injury via activation of the Akt and ERK1/2 signaling pathways and contributes to the neuroprotection of physical exercise in cerebral ischemia.Li DJ, Li YH, Yuan HB, Qu LF, Wang P. Li DJ, et al. Metabolism. 2017 Mar;68:31-42. doi: 10.1016/j.metabol.2016.12.003. Epub 2016 Dec 11. Metabolism. 2017. PMID: 28183451
- Brain Vascular Health in ALS Is Mediated through Motor Cortex Microvascular Integrity.Schreiber S, Bernal J, Arndt P, Schreiber F, Müller P, Morton L, Braun-Dullaeus RC, Valdés-Hernández MDC, Duarte R, Wardlaw JM, Meuth SG, Mietzner G, Vielhaber S, Dunay IR, Dityatev A, Jandke S, Mattern H. Schreiber S, et al. Cells. 2023 Mar 21;12(6):957. doi: 10.3390/cells12060957. Cells. 2023. PMID: 36980297 Free PMC article. Review.
- Recombinant Irisin Protects Against Alveolar Bone Destruction During Orthodontic Tooth Movement.Wu S, Wang J, Liu L, Pang Y, Li Z, Mu H. Wu S, et al. Inflammation. 2023 Mar 15. doi: 10.1007/s10753-023-01797-3. Online ahead of print. Inflammation. 2023. PMID: 36918436
- The Impact of the Six Pillars of Lifestyle Medicine on Brain Health.Jaqua E, Biddy E, Moore C, Browne G. Jaqua E, et al. Cureus. 2023 Feb 3;15(2):e34605. doi: 10.7759/cureus.34605. eCollection 2023 Feb. Cureus. 2023. PMID: 36883088 Free PMC article. Review.
- Recent advances on the molecular mechanisms of exercise-induced improvements of cognitive dysfunction.Lu Y, Bu FQ, Wang F, Liu L, Zhang S, Wang G, Hu XY. Lu Y, et al. Transl Neurodegener. 2023 Feb 27;12(1):9. doi: 10.1186/s40035-023-00341-5. Transl Neurodegener. 2023. PMID: 36850004 Free PMC article. Review.
- Irisin: An anti-inflammatory exerkine in aging and redox-mediated comorbidities.Trettel CDS, Pelozin BRA, Barros MP, Bachi ALL, Braga PGS, Momesso CM, Furtado GE, Valente PA, Oliveira EM, Hogervorst E, Fernandes T. Trettel CDS, et al. Front Endocrinol (Lausanne). 2023 Feb 10;14:1106529. doi: 10.3389/fendo.2023.1106529. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36843614 Free PMC article. Review.
-
- Prince M, et al. The global prevalence of dementia: a systematic review and meta-analysis. Alzheimer’s & Dementia 9, 63–75 e62 (2013). - PubMed
-
- Fernandez AM & Torres-Alemán I The many faces of insulin-like peptide signalling in the brain. Nature Reviews Neuroscience 13, 225–239 (2012). - PubMed
-
- Biessels GJ & Reagan LP Hippocampal insulin resistance and cognitive dysfunction. Nature Reviews Neuroscience 16, 660–671 (2015). - PubMed
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- Adolescent
- Adult
- Aged
- Alzheimer Disease / cerebrospinal fluid
- Alzheimer Disease / genetics
- Alzheimer Disease / metabolism*
- Alzheimer Disease / physiopathology*
- Animals
- Brain / metabolism
- Brain / pathology
- Disease Models, Animal
- Down-Regulation
- Female
- Fibronectins / cerebrospinal fluid
- Fibronectins / genetics
- Fibronectins / metabolism*
- Humans
- Long-Term Potentiation
- Male
- Memory Disorders / complications*
- Memory Disorders / physiopathology*
- Mice, Inbred C57BL
- Middle Aged
- Neuronal Plasticity*
- Neuroprotective Agents / pharmacology
- Neuroprotective Agents / therapeutic use
- Physical Conditioning, Animal*
- RNA, Messenger / genetics
- RNA, Messenger / metabolism
- Recombinant Proteins / pharmacology
- Recombinant Proteins / therapeutic use
- Signal Transduction
- FNDC5 protein, human
- FNDC5 protein, mouse
- Fibronectins
- Neuroprotective Agents
- RNA, Messenger
- Recombinant Proteins
- Full Text Sources
- Other Literature Sources
- Medical
- Molecular Biology Databases
![Figure 6.. FNDC5/irisin mediates the beneficial effects…](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6327967/bin/nihms-1511423-f0006.jpg)
References
- Prince M, et al. The global prevalence of dementia: a systematic review and meta-analysis. Alzheimer’s & Dementia 9, 63–75 e62 (2013).
- Ferreira ST, Lourenco MV, Oliveira MM & De Felice FG Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer’s disease. Frontiers in Cellular Neuroscience 9, 191 (2015).
- Fernandez AM & Torres-Alemán I The many faces of insulin-like peptide signalling in the brain. Nature Reviews Neuroscience 13, 225–239 (2012).
- Biessels GJ & Reagan LP Hippocampal insulin resistance and cognitive dysfunction. Nature Reviews Neuroscience 16, 660–671 (2015).
- McEwen BS Preserving neuroplasticity: Role of glucocorticoids and neurotrophins via phosphorylation. Proceedings of the National Academy of Sciences 112, 15544–15545 (2015).
- During MJ, et al. Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nature Medicine 9, 1173–1179 (2003).
- Chiu S-L, Chen C-M & Cline HT Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo. Neuron 58, 708–719 (2008).
- Grillo CA, et al. Hippocampal insulin resistance impairs spatial learning and synaptic plasticity. Diabetes 64, 3927–3936 (2015).
- Irving AJ & Harvey J Leptin regulation of hippocampal synaptic function in health and disease. Philos Trans R Soc Lond B Biol Sci 369, 20130155 (2014).
- Lourenco MV, Ferreira ST & De Felice FG Neuronal stress signaling and eIF2α phosphorylation as molecular links between Alzheimer’s disease and diabetes. Progress in Neurobiology 129, 37–57 (2015).
- Bomfim TR, et al. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease-associated Aβ oligomers. Journal of Clinical Investigation 122, 1339–1353 (2012).
- Talbot K, et al. Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. Journal of Clinical Investigation 122, 1316–1338 (2012).
- De Felice FG, Lourenco MV & Ferreira ST How does brain insulin resistance develop in Alzheimer’s disease? Alzheimer’s & Dementia 10, S26–S32 (2014).
- Wadman M US government sets out Alzheimer’s plan. Nature 485, 426–427 (2012).
- De Felice FG Alzheimer’s disease and insulin resistance: translating basic science into clinical applications. Journal of Clinical Investigation 123, 531–539 (2013).
- Boström P, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481, 463–468 (2012).
- Jedrychowski Mark P., et al. Detection and quantitation of circulating human irisin by tandem mass spectrometry. Cell Metabolism 22, 734–740 (2015).
- Wrann Christiane D., et al. Exercise Induces Hippocampal BDNF through a PGC-1α/FNDC5 Pathway. Cell Metabolism 18, 649–659 (2013).
- Chen K, et al. Irisin protects mitochondria function during pulmonary ischemia/reperfusion injury. Science Translational Medicine 9, eaao6298 (2017).
- Lee P, et al. Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. Cell Metabolism 19, 302–309 (2014).
- Schumacher MA, Chinnam N, Ohashi T, Shah RS & Erickson HP The structure of irisin reveals a novel intersubunit beta-sheet fibronectin type III (FNIII) dimer: implications for receptor activation. Journal of Biological Chemistry 288, 33738–33744 (2013).
- Mucke L & Selkoe DJ Neurotoxicity of amyloid β-protein: synaptic and network dysfunction. Cold Spring Harbor Perspectives in Medicine 2, 1–17 (2012).
- Sebollela A, et al. Amyloid-β oligomers induce differential gene expression in adult human brain slices. Journal of Biological Chemistry 287, 7436–7445 (2012).
- Colaianni G, et al. The myokine irisin increases cortical bone mass. Proceedings of the National Academy of Sciences 112, 12157–12162 (2015).
- Figueiredo CP, et al. Memantine rescues transient cognitive impairment caused by high-molecular-weight Aβ oligomers but not the persistent impairment induced by low-molecular-weight oligomers. Journal of Neuroscience 33, 9626–9634 (2013).
- Lourenco MV, et al. TNF-α mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer’s β-amyloid oligomers in mice and monkeys. Cell Metabolism 18, 831–843 (2013).
- Jankowsky JL, et al. Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomolecular Engineering 17, 157–165 (2001).
- Cheng A, et al. Involvement of PGC-1α in the formation and maintenance of neuronal dendritic spines. Nature Communications 3, 1250 (2012).
- Holcomb L, et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nature Medicine 4, 97–100 (1998).
- Ma T, et al. Suppression of eIF2α kinases alleviates Alzheimer’s disease–related plasticity and memory deficits. Nature Neuroscience 16, 1299–1305 (2013).
- Yang W, et al. Repression of the eIF2α kinase PERK alleviates mGluR-LTD impairments in a mouse model of Alzheimer’s disease. Neurobiology of Aging 41, 19–24 (2016).
- Trinh MA & Klann E Translational control by eIF2α kinases in long-lasting synaptic plasticity and long-term memory. Neurobiology of Learning and Memory 105, 93–99 (2013).
- Gong B, et al. Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. Journal of Clinical Investigation 114, 1624–1634 (2004).
- Vitolo OV, et al. Amyloid β-peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proceedings of the National Academy of Sciences 99, 13217–13221 (2002).
- Schaefer N, et al. The malleable brain: plasticity of neural circuits and behavior – a review from students to students. Journal of Neurochemistry 142, 790–811 (2017).
- Katsnelson A, De Strooper B & Zoghbi HY Neurodegeneration: From cellular concepts to clinical applications. Science Translational Medicine 8, 364ps318 (2016).
- Selkoe DJ Alzheimer’s disease is a synaptic failure. Science 298, 789–791 (2002).
- Lepeta K, et al. Synaptopathies: synaptic dysfunction in neurological disorders. Journal of Neurochemistry 138, 785–805 (2016).
- Zhang Y, et al. Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes 63, 514–525 (2014).
- Timmons JA, Baar K, Davidsen PK & Atherton PJ Is irisin a human exercise gene? Nature 488, E9–E10 (2012).
- Albrecht E, et al. Irisin – a myth rather than an exercise-inducible myokine. Scientific Reports 5, 8889 (2015).
- Martin KC & Kandel ER Cell adhesion molecules, CREB, and the formation of new synaptic connections. Neuron 17, 567–570 (1996).
- Suwabe K, et al. Rapid stimulation of human dentate gyrus function with acute mild exercise. Proceedings of the National Academy of Sciences 115, 10487–10492 (2018).
- van Praag H, Fleshner M, Schwartz MW & Mattson MP Exercise, energy intake, glucose homeostasis, and the brain. Journal of Neuroscience 34, 15139–15149 (2014).
- Neufer PD, et al. Understanding the cellular and molecular mechanisms of physical activity-induced health benefits. Cell Metabolism 22, 4–11 (2015).
- Baker LD, et al. Effects of aerobic exercise on mild cognitive impairment: a controlled trial. Archives of Neurology 67, 71–79 (2010).
- Buchman AS, et al. Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology 78, 1323–1329 (2012).
- Okonkwo OC, et al. Physical activity attenuates age-related biomarker alterations in preclinical AD. Neurology 83, 1753–1760 (2014).
- Muller S, et al. Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer’s disease. Alzheimer’s & Dementia (2018), in press.
- Mattson Mark P. Energy intake and exercise as determinants of brain health and vulnerability to injury and disease. Cell Metabolism 16, 706–722 (2012).
- Moon HY, et al. Running-Induced Systemic Cathepsin B Secretion Is Associated with Memory Function. Cell Metabolism 24, 332–340 (2016).
- Sleiman SF, et al. Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body β-hydroxybutyrate. eLife 5 (2016).
- Smith RW, Wang J, Bucking CP, Mothersill CE & Seymour CB Evidence for a protective response by the gill proteome of rainbow trout exposed to X-ray induced bystander signals. Proteomics 7, 4171–4180 (2007).
- Mendes ND, et al. Free-floating adult human brain-derived slice cultures as a model to study the neuronal impact of Alzheimer’s disease-associated Aβ oligomers. Journal of Neuroscience Methods 307, 203–209 (2018).
- Drummond C, et al. Deficits in narrative discourse elicited by visual stimuli are already present in patients with mild cognitive impairment. Frontiers in Aging Neuroscience 7, 96 (2015).
- Ledo JH, et al. Amyloid-β oligomers link depressive-like behavior and cognitive deficits in mice. Molecular Psychiatry 18, 1053–1054 (2013).
- Ledo JH, et al. Cross talk between brain innate immunity and serotonin signaling underlies depressive-like behavior induced by Alzheimer’s amyloid-β oligomers in mice. Journal of Neuroscience 36, 12106–12116 (2016).
- Trinchese F, et al. Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease. Journal of Clinical Investigation 118, 2796–2807 (2008).
- Alamed J, Wilcock DM, Diamond DM, Gordon MN & Morgan D Two-day radial-arm water maze learning and memory task; robust resolution of amyloid-related memory deficits in transgenic mice. Nature Protocols 1, 1671–1679 (2006).
- Puzzo D, et al. Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an Alzheimer’s disease mouse model. Journal of Neuroscience 29, 8075–8086 (2009).
- Madeira C, et al. d-serine levels in Alzheimer’s disease: implications for novel biomarker development. Translational Psychiatry 5, e561 (2015).
- Seixas Da Silva GS, et al. Amyloid-β oligomers transiently inhibits AMP-activated kinase and causes metabolic defects in hippocampal neurons. Journal of Biological Chemistry 292, 7395–7406 (2017).
- Gong B, et al. Ubiquitin hydrolase Uch-L1 rescues β-amyloid-induced decreases in synaptic function and contextual memory. Cell 126, 775–788 (2006).
- De Felice FG, et al. Aβ oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. Journal of Biological Chemistry 282, 11590–11601 (2007).
- Lambert MP, et al. Monoclonal antibodies that target pathological assemblies of Aβ. Journal of Neurochemistry 100, 23–35 (2007).
- Abràmoff MD, Magalhães PJ & Ram SJ Image processing with Image J. Biophotonics International 2004, 1–7 (2004).
- Livak KJ & Schmittgen TD Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) method. Methods 25, 402–408 (2001).
- Brito-Moreira J, et al. Interaction of amyloid-β (Aβ) oligomers with neurexin 2α and neuroligin 1 mediates synapse damage and memory loss in mice. Journal of Biological Chemistry 292, 7327–7337 (2017).
- Schmidt EK, Clavarino G, Ceppi M & Pierre P SUnSET, a nonradioactive method to monitor protein synthesis. Nature Methods 6, 275–277 (2009).
- Beckman D, et al. Prion protein modulates monoaminergic systems and depressive-like behavior in mice. Journal of Biological Chemistry 290, 20488–20498 (2015).
Source: PubMed